Merck KGaA sells allergy unit to Dermapharm, keeps autoinjector projectAcquisitions, Allergic Shock, Allergies, Auto-Injection Therapy, BusinessMerck KGaA agreed to sell the German drugmaker’s allergy business Allergopharma to Dermapharm SE for an undisclosed price, but will continue to develop an autoinjector to treat allergic shock. Read more February 19, 2020/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2020-02-19 10:41:232020-02-21 12:52:09Merck KGaA sells allergy unit to Dermapharm, keeps autoinjector project
